Truist Financial
HZNP

Truist Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Truist Financial’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,885
Closed -$218K – 2751
2023
Q3 		$218K Sell
1,885
-885
-32% -$95.1K ﹤0.01% 2420
2023
Q2 		$285K Sell
2,770
-4,469
-62% -$471K ﹤0.01% 2276
2023
Q1 		$790K Sell
7,239
-61,321
-89% -$6.78M ﹤0.01% 1688
2022
Q4 		$7.8M Sell
68,560
-17,805
-21% -$1.48M 0.01% 660
2022
Q3 		$5.34M Buy
86,365
+3,608
+4% +$252K 0.01% 760
2022
Q2 		$6.6M Sell
82,757
-11,732
-12% -$1.11M 0.01% 716
2022
Q1 		$9.94M Buy
94,489
+5,241
+6% +$511K 0.02% 638
2021
Q4 		$9.62M Buy
89,248
+2,086
+2% +$228K 0.01% 654
2021
Q3 		$9.55M Buy
87,162
+2,635
+3% +$274K 0.02% 655
2021
Q2 		$7.92M Buy
84,527
+4,636
+6% +$427K 0.01% 716
2021
Q1 		$7.35M Buy
79,891
+30,328
+61% +$2.56M 0.01% 704
2020
Q4 		$3.63M Buy
49,563
+38,638
+354% +$2.87M 0.01% 935
2020
Q3 		$848K Sell
10,925
-3,343
-23% -$230K ﹤0.01% 1442
2020
Q2 		$792K Buy
14,268
+3,944
+38% +$169K ﹤0.01% 1392
2020
Q1 		$305K Buy
10,324
+195
+2% +$6.6K ﹤0.01% 1849
2019
Q4 		$366K Buy
+10,129
New +$311K ﹤0.01% 2048

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Truist Financial's HZNP Position: Q4 2023 in Review

Truist Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 1,885 shares — an estimated $218K sold.

Truist Financial first reported a position in HZNP in Q4 2019 and held it in 16 quarters. The position peaked at $9.94M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Truist Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Truist Financial sold 1,885 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $218K.
  • Truist Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 16 quarters.
  • Truist Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $9.94M in Q1 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Truist Financial's 13F filing for Q4 2023, filed 2 Feb 2024.